Table 1. Patient clinic and histopathologic characteristics in relation to prognosis.
| Variable | Overall(n = 79) | Non-relapsed(n = 58) | Relapsed(n = 21) | p-value# |
|---|---|---|---|---|
| Median (range) | Median (range) | Median (range) | ||
| Age | 57 (33–89) | 57 (33–89) | 59 (42–79) | 0.698 |
| No. (%) | No. (%) | No. (%) | ||
| Histological subtype | ||||
| A | 23 (29.1) | 17 (29.3) | 6 (28.6) | 0.984 |
| B | 21 (26.6) | 16 (27.6) | 5 (23.8) | |
| C | 20 (25.3) | 14 (24.1) | 6 (28.5) | |
| D | 15 (19.0) | 11 (19.0) | 4 (19.1) | |
| ER | ||||
| 0 | 31 (39.2) | 23 (39.7) | 8 (38.1) | 0.900 |
| >0 | 48 (60.8) | 35 (60.3) | 13 (61.9) | |
| PGR | ||||
| 0 | 40 (50.6) | 29 (50.0) | 11 (52.4) | 0.852 |
| > 0 | 39 (49.4) | 29 (50.0) | 10 (47.6) | |
| KI67 | ||||
| 0–19 | 39 (49.4) | 29 (50.0) | 10 (47.6) | 0.852 |
| ≥ 20 | 40 (50.6) | 29 (50.0) | 11 (52.4) | |
| HER2 Status | ||||
| NEG | 50 (64.9) | 37 (64.9) | 13 (65.0) | 0.994 |
| POS | 27 (35.1) | 20 (35.1) | 7 (35.0) | |
| Grading | ||||
| G1 | 4 (5.5) | 3 (5.4) | 1 (5.9) | 1.000 |
| G2 | 27 (36.9) | 21 (37.5) | 6 (35.3) | |
| G3 | 42 (57.6) | 32 (57.1) | 10 (58.8) | |
| Therapy | ||||
| CT | 27 (39.1) | 19 (38.0) | 8 (42.1) | 0.353 |
| HT | 21 (30.4) | 18 (36.0) | 3 (15.8) | |
| CT + BT | 14 (20.3) | 9 (18.0) | 5 (26.3) | |
| CT + HT +/– BT | 7 (10.2) | 4 (8.0) | 3 (15.8) |
#Two-sample Wilcoxon rank-sum (Mann-Whitney) test for age, fisher exact test for histological subtype, grading and type of therapy and chi square for the remaining variables.
CT, chemotherapy; HT, hormonal therapy; BT, biological therapy.